Standards FAQ Details | Joint Commission

We published an updated version of our Privacy & Cookies Statement on May 18, 2018. Please take the time to read the updated Privacy & Cookies Statement. This site uses cookies and other tracking technologies to assist with navigation, providing feedback, analyzing your use of our products and services, assisting with our promotional and marketing efforts, and provide content from third parties. Cookies Statement 

Follow us on Twitter Friend us on Facebook Vimeo linkedIn Share with your Friends Print this Page
Friday 9:53 CST, May 25, 2018

Standards FAQ Details


Medication Management (MM) (Hospital and Hospital Clinics / Hospitals)

Medication Administration - Titration Orders
Modify | March 31, 2017
Does The Joint Commission require specific elements for titration orders when such orders are permitted by an organization and what other quality or safety advances should be considered ?

Titration orders are generally defined as those in which the medication dose is either progressively increased or decreased in response to the patient’s status. Organizations are required to define, by policy, if titration orders are deemed acceptable for use.  The elements of performance found in the Medication Management (MM) chapter at MM.04.01.01 outline the policy requirements.
Required elements for medication titration orders
  • Medication name
  • Medication route
  • Initial or starting rate of infusion (dose/min)
  • Incremental units the rate can be increased or decreased
  • Frequency for incremental doses (how often dose(rate) can be increased or decreased
  • Maximum rate (dose) of infusion
  • Objective clinical endpoint (RASS score, CAM score, etc)
For example, a titrated medication order would say: 
Start [medication name] drip at 10 mcg/kg/min.  Increase by 5 mcg/kg/min every 5 minutes until desired patient response and/or numeric target (e.g. RASS =3) is achieved. Maximum rate of 60 mcg/kg/min.
Goals when developing requirements for safe administration:
• Compliance with manufacturer’s Instructions For Use (IFU) for safe administration
• Consistent administration practices among nurses and other practitioners
• Ensure the patient response is achieved/sustained
• Nursing not placed in a position of making dosing/administration decisions that may conflict with their scope of practice
• Documentation accurately reflects order changes, patient assessments, etc.

The organization’s clinical and pharmacy leadership are encouraged to reach out to their state’s pharmacy and/or nursing boards to determine if any additional requirements need to be considered.

Was this response helpful?

Comments (Optional - For internal use only)
Thank you for your feedback!